Process View
The aggregation, arrangement, and bonding together of a set of components to form a cell-substrate adherens junction.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cell substrate adherens junction assembly"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.988 | Human | |
| S100A6 | S100 calcium binding protein A6 | 0.986 | Human | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.956 | Human | |
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.950 | Human | |
| VEGFA | vascular endothelial growth factor A | 0.936 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.898 | ||
| S100B | S100 calcium binding protein B | 0.880 | Human | |
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.734 | ||
| S100A8 | S100 calcium binding protein A8 | 0.707 | Human | |
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.694 | ||
| ANGPT2 | angiopoietin 2 | 0.688 | ||
| ZYX | zyxin | 0.682 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.661 | ||
| ENG | endoglin | 0.660 | ||
| FLNA | filamin A, alpha | 0.641 | ||
| S100A9 | S100 calcium binding protein A9 | 0.617 | Human | |
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.608 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.583 | ||
| NRP1 | neuropilin 1 | 0.566 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.527 | Rat | |
| SMAD2 | SMAD family member 2 | 0.523 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.521 | ||
| NCK2 | NCK adaptor protein 2 | 0.467 | ||
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.426 | ||
| S100A1 | S100 calcium binding protein A1 | 0.402 | Human | |
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.353 | ||
| ILK | integrin-linked kinase | 0.344 | ||
| TSG101 | tumor susceptibility gene 101 | 0.342 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.319 | Human | |
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.316 | ||
| ANXA2 | annexin A2 | 0.302 | ||
| EGFR | epidermal growth factor receptor | 0.281 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.279 | ||
| BMP2 | bone morphogenetic protein 2 | 0.258 | ||
| SFN | stratifin | 0.247 | ||
| FN1 | fibronectin 1 | 0.244 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.242 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.222 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.214 | Human | |
| LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.200 | ||
| EFNA1 | ephrin-A1 | 0.192 | Human | |
| EPHA2 | EPH receptor A2 | 0.191 | Human | |
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.190 | Human | |
| S100A11 | S100 calcium binding protein A11 | 0.177 | Human | |
| ZNF746 | zinc finger protein 746 | 0.172 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.169 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.165 | ||
| VCL | vinculin | 0.161 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.143 | Human | |
| SMAD7 | SMAD family member 7 | 0.141 | ||
| FHL2 | four and a half LIM domains 2 | 0.139 | ||
| ACTN1 | actinin, alpha 1 | 0.135 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.134 | ||
| S100A4 | S100 calcium binding protein A4 | 0.133 | Human | |
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.133 | Human | |
| TCF4 | transcription factor 4 | 0.129 | ||
| GIT2 | G protein-coupled receptor kinase interacting ArfGAP 2 | 0.110 | ||
| ANGPT1 | angiopoietin 1 | 0.102 | ||
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.100 | ||
| ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.099 | ||
| LMNA | lamin A/C | 0.095 | ||
| PDLIM1 | PDZ and LIM domain 1 | 0.095 | ||
| PGF | placental growth factor | 0.094 | Human | |
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.089 | Human | |
| GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 0.088 | ||
| PVRL1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) | 0.086 | ||
| TJP1 | tight junction protein 1 (zona occludens 1) | 0.083 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.082 | ||
| AREG | amphiregulin | 0.077 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.076 | ||
| EMP3 | epithelial membrane protein 3 | 0.075 | ||
| SH3BGRL3 | SH3 domain binding glutamic acid-rich protein like 3 | 0.070 | ||
| MYOZ1 | myozenin 1 | 0.067 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.065 | ||
| ACVR1 | activin A receptor, type I | 0.065 | Human | |
| BCL2L1 | BCL2-like 1 | 0.064 | ||
| KCNA5 | potassium voltage-gated channel, shaker-related subfamily, member 5 | 0.064 | ||
| GDF5 | growth differentiation factor 5 | 0.061 | ||
| LPXN | leupaxin | 0.060 | Human | |
| TRIP6 | thyroid hormone receptor interactor 6 | 0.060 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.057 | Human | |
| TLN1 | talin 1 | 0.057 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.056 | ||
| FKBP4 | FK506 binding protein 4, 59kDa | 0.056 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.055 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.055 | ||
| CD63 | CD63 molecule | 0.055 | ||
| RHOG | ras homolog gene family, member G (rho G) | 0.054 | Human | |
| CALD1 | caldesmon 1 | 0.054 | ||
| GIT1 | G protein-coupled receptor kinase interacting ArfGAP 1 | 0.053 | ||
| LIMK1 | LIM domain kinase 1 | 0.052 | ||
| MSN | moesin | 0.051 | ||
| CRIM1 | cysteine rich transmembrane BMP regulator 1 (chordin-like) | 0.049 | ||
| PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) | 0.049 | ||
| SEMA6A | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A | 0.049 | ||
| LIMS1 | LIM and senescent cell antigen-like domains 1 | 0.047 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.047 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.046 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.045 | ||
| EPHA3 | EPH receptor A3 | 0.044 | ||
| RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | 0.044 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.044 | ||
| CAV2 | caveolin 2 | 0.044 | ||
| FXYD5 | FXYD domain containing ion transport regulator 5 | 0.044 | ||
| S100A2 | S100 calcium binding protein A2 | 0.043 | Human | |
| MYH9 | myosin, heavy chain 9, non-muscle | 0.043 | ||
| RHOC | ras homolog gene family, member C | 0.042 | ||
| RHOA | ras homolog gene family, member A | 0.041 | ||
| AR | androgen receptor | 0.040 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.040 | ||
| PTRF | polymerase I and transcript release factor | 0.039 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.039 | ||
| PARVA | parvin, alpha | 0.037 | ||
| BMP4 | bone morphogenetic protein 4 | 0.037 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.037 | ||
| EPHA7 | EPH receptor A7 | 0.036 | Human | |
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.035 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.035 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.034 | ||
| PDGFC | platelet derived growth factor C | 0.034 | ||
| THBS1 | thrombospondin 1 | 0.034 | ||
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.033 | Human | |
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.032 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.032 | ||
| EPHB3 | EPH receptor B3 | 0.031 | Human | |
| ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | 0.030 | ||
| BTRC | beta-transducin repeat containing | 0.030 | ||
| PTEN | phosphatase and tensin homolog | 0.030 | ||
| NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 0.030 | ||
| EHD1 | EH-domain containing 1 | 0.030 | ||
| PRKCDBP | protein kinase C, delta binding protein | 0.029 | ||
| DIAPH1 | diaphanous homolog 1 (Drosophila) | 0.029 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.029 | Human | |
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.029 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.028 | ||
| LGALS3 | lectin, galactoside-binding, soluble, 3 | 0.028 | ||
| RRAS | related RAS viral (r-ras) oncogene homolog | 0.028 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.028 | ||
| SMTN | smoothelin | 0.028 | ||
| KIAA1033 | KIAA1033 | 0.028 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.028 | ||
| SKIL | SKI-like oncogene | 0.027 | ||
| ACTN4 | actinin, alpha 4 | 0.027 | Human | |
| KITLG | KIT ligand | 0.027 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.027 | ||
| PHC2 | polyhomeotic homolog 2 (Drosophila) | 0.027 | ||
| FURIN | furin (paired basic amino acid cleaving enzyme) | 0.027 | ||
| ZNF512B | zinc finger protein 512B | 0.027 | ||
| AGER | advanced glycosylation end product-specific receptor | 0.027 | ||
| S100P | S100 calcium binding protein P | 0.026 | Human | |
| CARD11 | caspase recruitment domain family, member 11 | 0.026 | ||
| PAK2 | p21 protein (Cdc42/Rac)-activated kinase 2 | 0.026 | ||
| TSC2 | tuberous sclerosis 2 | 0.025 | ||
| GNB2 | guanine nucleotide binding protein (G protein), beta polypeptide 2 | 0.025 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.025 | ||
| DLC1 | deleted in liver cancer 1 | 0.024 | Mouse | |
| TAGLN2 | transgelin 2 | 0.024 | ||
| HOXA1 | homeobox A1 | 0.023 | ||
| CNN2 | calponin 2 | 0.023 | ||
| MAP2K3 | mitogen-activated protein kinase kinase 3 | 0.023 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.023 | ||
| PEA15 | phosphoprotein enriched in astrocytes 15 | 0.023 | ||
| ATG14 | ATG14 autophagy related 14 homolog (S. cerevisiae) | 0.023 | ||
| CDC42EP1 | CDC42 effector protein (Rho GTPase binding) 1 | 0.023 | ||
| NFAT5 | nuclear factor of activated T-cells 5, tonicity-responsive | 0.023 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.023 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.022 | ||
| FEM1B | fem-1 homolog b (C. elegans) | 0.022 | ||
| FYB | FYN binding protein | 0.022 | ||
| COTL1 | coactosin-like 1 (Dictyostelium) | 0.022 | ||
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.022 | ||
| MED15 | mediator complex subunit 15 | 0.022 | ||
| TMSB10 | thymosin beta 10 | 0.022 | ||
| LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.022 | ||
| CSNK1D | casein kinase 1, delta | 0.021 | ||
| LY6G6F | lymphocyte antigen 6 complex, locus G6F | 0.021 | ||
| S100A10 | S100 calcium binding protein A10 | 0.021 | ||
| LDLR | low density lipoprotein receptor | 0.021 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.020 | ||
| FAF1 | Fas (TNFRSF6) associated factor 1 | 0.020 | ||
| PHF21A | PHD finger protein 21A | 0.020 | ||
| JAG1 | jagged 1 | 0.020 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.020 | ||
| MMP16 | matrix metallopeptidase 16 (membrane-inserted) | 0.020 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.020 | ||
| GORAB | golgin, RAB6-interacting | 0.020 | ||
| GPRASP2 | G protein-coupled receptor associated sorting protein 2 | 0.019 | ||
| NCK1 | NCK adaptor protein 1 | 0.019 | ||
| S100A12 | S100 calcium binding protein A12 | 0.019 | Human | |
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.019 | ||
| NOTCH1 | notch 1 | 0.019 | ||
| EFHD2 | EF-hand domain family, member D2 | 0.018 | ||
| MAP2 | microtubule-associated protein 2 | 0.018 | ||
| HGS | hepatocyte growth factor-regulated tyrosine kinase substrate | 0.018 | ||
| ANTXR2 | anthrax toxin receptor 2 | 0.018 | ||
| MYO9B | myosin IXB | 0.018 | ||
| LTBP2 | latent transforming growth factor beta binding protein 2 | 0.018 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.018 | ||
| FLNB | filamin B, beta | 0.018 | ||
| WT1 | Wilms tumor 1 | 0.018 | ||
| CNKSR1 | connector enhancer of kinase suppressor of Ras 1 | 0.018 | ||
| RB1 | retinoblastoma 1 | 0.018 | ||
| AMOTL2 | angiomotin like 2 | 0.018 | ||
| DAG1 | dystroglycan 1 (dystrophin-associated glycoprotein 1) | 0.018 | ||
| CSRP1 | cysteine and glycine-rich protein 1 | 0.018 | ||
| MAP7D1 | MAP7 domain containing 1 | 0.018 | ||
| SBF1 | SET binding factor 1 | 0.018 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.018 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.017 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.017 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.017 | ||
| PLEC | plectin | 0.017 | ||
| ACTN2 | actinin, alpha 2 | 0.017 | ||
| HTT | huntingtin | 0.017 | ||
| SH2D1A | SH2 domain containing 1A | 0.017 | ||
| STK10 | serine/threonine kinase 10 | 0.017 | ||
| LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.017 | ||
| PDE2A | phosphodiesterase 2A, cGMP-stimulated | 0.017 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.017 | ||
| EP300 | E1A binding protein p300 | 0.017 | ||
| VASP | vasodilator-stimulated phosphoprotein | 0.017 | ||
| FSTL1 | follistatin-like 1 | 0.017 | ||
| ACVRL1 | activin A receptor type II-like 1 | 0.017 | ||
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.017 | ||
| CAPG | capping protein (actin filament), gelsolin-like | 0.016 | ||
| CD97 | CD97 molecule | 0.016 | ||
| SEMA3F | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F | 0.016 | ||
| ADRBK1 | adrenergic, beta, receptor kinase 1 | 0.016 | ||
| VWF | von Willebrand factor | 0.016 | ||
| SPARCL1 | SPARC-like 1 (hevin) | 0.016 | ||
| PAWR | PRKC, apoptosis, WT1, regulator | 0.016 | ||
| PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 0.016 | ||
| PDCD6IP | programmed cell death 6 interacting protein | 0.016 | ||
| SORBS3 | sorbin and SH3 domain containing 3 | 0.016 | ||
| UBE2R2 | ubiquitin-conjugating enzyme E2R 2 | 0.016 | ||
| ELF4 | E74-like factor 4 (ets domain transcription factor) | 0.016 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.016 | ||
| PKP3 | plakophilin 3 | 0.015 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.015 | ||
| FAM65A | family with sequence similarity 65, member A | 0.015 | ||
| HES1 | hairy and enhancer of split 1, (Drosophila) | 0.015 | ||
| EPHB2 | EPH receptor B2 | 0.015 | Human | |
| GJA1 | gap junction protein, alpha 1, 43kDa | 0.015 | ||
| CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0.015 | ||
| SORBS2 | sorbin and SH3 domain containing 2 | 0.015 | ||
| SBNO2 | strawberry notch homolog 2 (Drosophila) | 0.015 | ||
| VEGFC | vascular endothelial growth factor C | 0.015 | Human | |
| CTTN | cortactin | 0.015 | ||
| LASP1 | LIM and SH3 protein 1 | 0.015 | ||
| AHNAK | AHNAK nucleoprotein | 0.015 | ||
| PXN | paxillin | 0.015 | Human Mouse | |
| MAP3K11 | mitogen-activated protein kinase kinase kinase 11 | 0.015 | ||
| JUP | junction plakoglobin | 0.014 | ||
| KIAA1539 | KIAA1539 | 0.014 | ||
| TBC1D10B | TBC1 domain family, member 10B | 0.014 | ||
| ERBB2IP | erbb2 interacting protein | 0.014 | ||
| INHBB | inhibin, beta B | 0.014 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.014 | ||
| PVRL3 | poliovirus receptor-related 3 | 0.014 | ||
| TMEM108 | transmembrane protein 108 | 0.014 | ||
| GNL3L | guanine nucleotide binding protein-like 3 (nucleolar)-like | 0.014 | ||
| C1orf93 | chromosome 1 open reading frame 93 | 0.014 | ||
| EZR | ezrin | 0.014 | ||
| ANXA5 | annexin A5 | 0.014 | ||
| MYL9 | myosin, light chain 9, regulatory | 0.014 | ||
| CSK | c-src tyrosine kinase | 0.014 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.014 | Human | |
| LPPR2 | lipid phosphate phosphatase-related protein type 2 | 0.014 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.014 | ||
| RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0.014 | Human | |
| NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | 0.014 | ||
| CD81 | CD81 molecule | 0.014 | ||
| CORO1A | coronin, actin binding protein, 1A | 0.014 | ||
| CSTA | cystatin A (stefin A) | 0.013 | ||
| EFNA5 | ephrin-A5 | 0.013 | ||
| GJA4 | gap junction protein, alpha 4, 37kDa | 0.013 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.013 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.013 | ||
| TRIO | triple functional domain (PTPRF interacting) | 0.013 | ||
| TRIM63 | tripartite motif containing 63 | 0.013 | ||
| F2R | coagulation factor II (thrombin) receptor | 0.013 | ||
| PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.013 | ||
| PNPLA6 | patatin-like phospholipase domain containing 6 | 0.013 | ||
| ARHGEF11 | Rho guanine nucleotide exchange factor (GEF) 11 | 0.013 | ||
| ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0.013 | ||
| MEF2A | myocyte enhancer factor 2A | 0.013 | ||
| PDLIM7 | PDZ and LIM domain 7 (enigma) | 0.013 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.013 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.013 | ||
| RYBP | RING1 and YY1 binding protein | 0.013 | ||
| MCC | mutated in colorectal cancers | 0.013 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.013 | ||
| PITPNM1 | phosphatidylinositol transfer protein, membrane-associated 1 | 0.013 | ||
| EMCN | endomucin | 0.013 | ||
| CD248 | CD248 molecule, endosialin | 0.013 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.013 | ||
| CD34 | CD34 molecule | 0.013 | ||
| HDGF | hepatoma-derived growth factor | 0.012 | ||
| MCAM | melanoma cell adhesion molecule | 0.012 | ||
| DCTN1 | dynactin 1 | 0.012 | ||
| GOLGB1 | golgin B1 | 0.012 | ||
| C15orf39 | chromosome 15 open reading frame 39 | 0.012 | ||
| PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.012 | ||
| NOTCH4 | notch 4 | 0.012 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.012 | ||
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.012 | ||
| ITGA7 | integrin, alpha 7 | 0.012 | ||
| BTBD7 | BTB (POZ) domain containing 7 | 0.012 | ||
| BIK | BCL2-interacting killer (apoptosis-inducing) | 0.012 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.012 | ||
| SH3GL1 | SH3-domain GRB2-like 1 | 0.012 | ||
| RABGAP1 | RAB GTPase activating protein 1 | 0.012 | ||
| AP2A2 | adaptor-related protein complex 2, alpha 2 subunit | 0.012 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.012 | ||
| ITGA6 | integrin, alpha 6 | 0.012 | ||
| ACTN3 | actinin, alpha 3 | 0.012 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.012 | ||
| VAT1 | vesicle amine transport protein 1 homolog (T. californica) | 0.012 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.012 | ||
| DLG4 | discs, large homolog 4 (Drosophila) | 0.012 | ||
| ARHGAP1 | Rho GTPase activating protein 1 | 0.012 | ||
| DLGAP4 | discs, large (Drosophila) homolog-associated protein 4 | 0.012 | ||
| TCAP | titin-cap (telethonin) | 0.012 | ||
| PRKCQ | protein kinase C, theta | 0.012 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.012 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.011 | ||
| BGN | biglycan | 0.011 | ||
| FEZ1 | fasciculation and elongation protein zeta 1 (zygin I) | 0.011 | ||
| PRELP | proline/arginine-rich end leucine-rich repeat protein | 0.011 | ||
| RBMS1 | RNA binding motif, single stranded interacting protein 1 | 0.011 | ||
| CD151 | CD151 molecule (Raph blood group) | 0.011 | ||
| AQP1 | aquaporin 1 (Colton blood group) | 0.011 | ||
| ACVR1B | activin A receptor, type IB | 0.011 | Human | |
| PKD2 | polycystic kidney disease 2 (autosomal dominant) | 0.011 | ||
| APC | adenomatous polyposis coli | 0.011 | ||
| CXXC5 | CXXC finger protein 5 | 0.011 | ||
| RAC3 | ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) | 0.011 | ||
| GHR | growth hormone receptor | 0.011 | ||
| PLXDC1 | plexin domain containing 1 | 0.011 | ||
| PTPRD | protein tyrosine phosphatase, receptor type, D | 0.011 | Human | |
| SORBS1 | sorbin and SH3 domain containing 1 | 0.011 | Mouse | |
| SIRPA | signal-regulatory protein alpha | 0.011 | ||
| MAP1S | microtubule-associated protein 1S | 0.011 | ||
| ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 0.011 | ||
| MAP4K4 | mitogen-activated protein kinase kinase kinase kinase 4 | 0.011 | ||
| DOCK8 | dedicator of cytokinesis 8 | 0.011 | ||
| RPS27L | ribosomal protein S27-like | 0.011 | ||
| ZNF426 | zinc finger protein 426 | 0.011 | ||
| ZEB1 | zinc finger E-box binding homeobox 1 | 0.011 | ||
| AKAP12 | A kinase (PRKA) anchor protein 12 | 0.011 | ||
| CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0.011 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.011 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.011 | ||
| LAMB3 | laminin, beta 3 | 0.011 | ||
| CSNK1E | casein kinase 1, epsilon | 0.011 | ||
| PSG5 | pregnancy specific beta-1-glycoprotein 5 | 0.011 | ||
| LAMA4 | laminin, alpha 4 | 0.011 | ||
| PARVB | parvin, beta | 0.011 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.011 | ||
| FAM129B | family with sequence similarity 129, member B | 0.011 | ||
| SLIT2 | slit homolog 2 (Drosophila) | 0.011 | ||
| PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.011 | ||
| EPHB6 | EPH receptor B6 | 0.011 | Human | |
| MYH11 | myosin, heavy chain 11, smooth muscle | 0.011 | ||
| ICAM2 | intercellular adhesion molecule 2 | 0.011 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.011 | ||
| GFI1B | growth factor independent 1B transcription repressor | 0.011 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.011 | Rat | |
| AXL | AXL receptor tyrosine kinase | 0.011 | ||
| STAB1 | stabilin 1 | 0.011 | ||
| PMEPA1 | prostate transmembrane protein, androgen induced 1 | 0.011 | ||
| SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 0.011 | ||
| PPAP2B | phosphatidic acid phosphatase type 2B | 0.011 | ||
| TBC1D1 | TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 | 0.010 | ||
| KCNA4 | potassium voltage-gated channel, shaker-related subfamily, member 4 | 0.010 | ||
| MATK | megakaryocyte-associated tyrosine kinase | 0.010 | ||
| RRM2B | ribonucleotide reductase M2 B (TP53 inducible) | 0.010 | ||
| YY1 | YY1 transcription factor | 0.010 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.010 | ||
| CD9 | CD9 molecule | 0.010 | ||
| NOS3 | nitric oxide synthase 3 (endothelial cell) | 0.010 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.010 | ||
| CHD3 | chromodomain helicase DNA binding protein 3 | 0.010 | ||
| INPPL1 | inositol polyphosphate phosphatase-like 1 | 0.010 | ||
| EFNB1 | ephrin-B1 | 0.010 | Human | |
| FGFR3 | fibroblast growth factor receptor 3 | 0.010 | ||
| PKN1 | protein kinase N1 | 0.010 | ||
| PFN1 | profilin 1 | 0.010 | ||
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.010 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.010 | ||
| FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | 0.010 | ||
| TACC1 | transforming, acidic coiled-coil containing protein 1 | 0.010 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.010 | ||
| TTN | titin | 0.010 |